Antifungal potential of disulfiram

Seema Khan1, Smita Singhal, Tarun Mathur

  • 1Department of Infectious Diseases, New Drug Discovery Research, R and D III, Sarhaul, Sector-18, Ranbaxy Research Laboratories, Gurgaon-122001, India.

Insights

Disulfiram, an established alcohol-deterrent drug, demonstrates significant antifungal properties against yeast and Aspergillus species. This finding suggests potential new therapeutic applications for disulfiram beyond alcohol deterrence.

Area of Science:

  • Pharmacology
  • Mycology
  • Antimicrobial Research

Background:

  • Disulfiram is an FDA-approved drug used to treat alcohol dependence, known for its safety and bioavailability.
  • Recent research indicates disulfiram modulates P-glycoprotein efflux pumps.
  • The antifungal potential of disulfiram has not been previously explored.

Purpose of the Study:

  • To investigate the antifungal activity of disulfiram against common fungal pathogens.
  • To determine the minimum inhibitory concentration (MIC) of disulfiram for yeast and Aspergillus species.

Main Methods:

  • Minimum Inhibitory Concentration (MIC) assays were performed.
  • Disulfiram's efficacy was tested against both fluconazole-sensitive and fluconazole-resistant yeast strains.
  • Activity against Aspergillus species was also evaluated.

Main Results:

  • Disulfiram exhibited potent antifungal activity against yeast isolates, with MIC50 and MIC90 values of 4 and 8 microg/ml, respectively.
  • The drug was effective across a MIC range of 1-16 micro g/ml for both susceptible and resistant yeast.
  • Disulfiram demonstrated fungicidal activity against Aspergillus spp., with MIC50 and MIC90 values of 2 and 8 microg/ml.

Conclusions:

  • Disulfiram possesses significant antifungal properties against yeast and Aspergillus species.
  • The established safety profile of disulfiram suggests its potential repurposing for fungal infections.
  • Further research is warranted to explore disulfiram's clinical utility as an antifungal agent.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...